Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 1
2010 2
2011 1
2014 2
2015 2
2018 2
2023 3
2024 4
2025 4

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

19 results

Results by year

Filters applied: . Clear all
Page 1
Childhood Arthritis and Rheumatology Research Alliance Biologic Disease-Modifying Antirheumatic Drug Consensus Treatment Plans for Refractory Moderately Severe Juvenile Dermatomyositis.
Tarvin SE, Sherman MA, Kim H, Balmuri N, Brown AG, Chow A, Gewanter HL, de Guzman MM, Huber AM, Kim S, Klein-Gitelman MS, Perron MM, Robinson AB, Sabbagh SE, Savani S, Shenoi S, Spitznagle J, Stingl C, Syverson G, Tory H, Spencer C; Childhood Arthritis and Rheumatology Research Alliance Juvenile Dermatomyositis Workgroup. Tarvin SE, et al. Arthritis Care Res (Hoboken). 2024 Nov;76(11):1532-1539. doi: 10.1002/acr.25393. Epub 2024 Aug 14. Arthritis Care Res (Hoboken). 2024. PMID: 38937134
Treating juvenile dermatomyositis to target: Paediatric Rheumatology European Society/Childhood Arthritis and Rheumatology Research Alliance-endorsed recommendations from an international task force.
Ravelli A, Rosina S, MacMahon JM, Baird T, Rebollo-Giménez AI, Hinze C, McCann LJ, Reed AM, Rider LG, Arvigo M, Bader-Meunier B, Bruno C, Caifeng L, Campanilho-Marques R, Cuccato S, Fiorillo C, Hahn NA, Huber AM, Jansen M, Kasapcopur O, Katsikas MM, Kim S, Livermore P, Maillard S, Malattia C, Migowa AN, Miyamae T, Murphy R, Nicolai R, Papadopoulou C, Pilkington C, Sanner H, Sawhney S, Smolewska E, Tarvin SE, Tiller G, Toplak N, Wedderburn LR, Bovis F, Consolaro A, Feldman BM. Ravelli A, et al. Among authors: tarvin se. Ann Rheum Dis. 2025 Jul;84(7):1055-1067. doi: 10.1016/j.ard.2025.04.024. Epub 2025 May 22. Ann Rheum Dis. 2025. PMID: 40410052
Biomarker Changes in Response to Tofacitinib Treatment in Patients With Polyarticular-Course Juvenile Idiopathic Arthritis.
Ogbu EA, Brunner HI, Eloseily E, Aviel YB, Nanda K, Schmeling H, Tory H, Uziel Y, Viola DO, Wahezi DM, Tarvin SE, Sproles A, Chen C, Ruperto N, Huang B, Grom A, Thornton S; Investigators of the PRINTO and PRCSG Networks. Ogbu EA, et al. Among authors: tarvin se. Arthritis Care Res (Hoboken). 2024 Dec;76(12):1723-1732. doi: 10.1002/acr.25417. Epub 2024 Sep 17. Arthritis Care Res (Hoboken). 2024. PMID: 39135452 Free PMC article.
Approach to Janus kinase inhibition for juvenile dermatomyositis among CARRA and PReS providers.
Sherman MA, Nicolai R, Datyner EK, Rosina S, Hamilton A, Ardalan K, Bader-Meunier B, Brown AG, Jansen MHA, Kim S, Lang B, Campanilho-Marques R, McCann LJ, Sanner H, Veldkamp SR, Wilkinson MGL, Yi BY, Kim H, Tarvin SE, Papadopoulou C; CARRA JDM Therapeutics Workgroup and the PReS JDM Working Party. Sherman MA, et al. Among authors: tarvin se. Rheumatology (Oxford). 2025 Aug 1;64(8):4732-4737. doi: 10.1093/rheumatology/keaf086. Rheumatology (Oxford). 2025. PMID: 39928372 Free PMC article.
Treatment outcomes in 63 cases of juvenile dermatomyositis-associated calcinosis.
Yi BY, Wahezi DM, Covert L, Ardalan K, Hui-Yuen J, Vasquez-Canizares N, Mosa DM, Jones M, Correll C, Begezda A, Shenoi S, Wu EY, Kovalick LK, Lapin WB, Tarvin SE, Oliver MS, Rodriguez MM, Marmor I, Baszis KW, Taxter AJ, Hanson AC, Crowson CS, Orandi AB; CARRA Juvenile Dermatomyositis, Calcinosis Subcommittee. Yi BY, et al. Among authors: tarvin se. Clin Exp Rheumatol. 2025 Jul 25:10.55563/clinexprheumatol/35pbbq. doi: 10.55563/clinexprheumatol/35pbbq. Online ahead of print. Clin Exp Rheumatol. 2025. PMID: 40737048 Free PMC article.
Treatment escalation patterns to start biologics in refractory moderate juvenile dermatomyositis among members of the Childhood Arthritis and Rheumatology Research Alliance.
Sherman MA, Kim H, Banschbach K, Brown A, Gewanter HL, Lang B, Perron M, Robinson AB, Spitznagle J, Stingl C, Syverson G, Tory HO, Spencer CH, Tarvin SE. Sherman MA, et al. Among authors: tarvin se. Pediatr Rheumatol Online J. 2023 Jan 6;21(1):3. doi: 10.1186/s12969-022-00785-5. Pediatr Rheumatol Online J. 2023. PMID: 36609397 Free PMC article.
19 results